Literature DB >> 19109163

Genome-wide innate immune responses in HIV-1-infected macrophages are preserved despite attenuation of the NF-kappa B activation pathway.

Mahdad Noursadeghi1, Jhen Tsang, Robert F Miller, Sarah Straschewski, Paul Kellam, Benjamin M Chain, David R Katz.   

Abstract

Macrophages contribute to HIV-1 infection at many levels. They provide permissive cells at the site of inoculation, augment virus transfer to T cells, generate long-lived viral reservoirs, and cause bystander cell apoptosis. A body of evidence suggests that the role of macrophages in cellular host defense is also compromised by HIV-1 infection. In this respect, macrophages are potent cells of the innate immune system that initiate and regulate wide-ranging immunological responses. This study focuses on the effect of HIV-1 infection on innate immune responses by macrophages at the level of signal transduction, whole genome transcriptional profiling, and cytokine secretion. We show that in an ex vivo model, M-CSF-differentiated monocyte-derived macrophages uniformly infected with replicating CCR5-tropic HIV-1, without cytopathic effect, exhibit selective attenuation of the NF-kappaB activation pathway in response to TLR4 and TLR2 stimulation. However, functional annotation clustering analysis of genome-wide transcriptional responses to LPS stimulation suggests substantial preservation of gene expression changes at the systems level, with modest attenuation of a subset of up-regulated LPS-responsive genes, and no effect on a selection of inflammatory cytokine responses at the protein level. These results extend existing reports of inhibitory interactions between HIV-1 accessory proteins and NF-kappaB signaling pathways, and whole genome expression profiling provides comprehensive assessment of the consequent effects on immune response gene expression. Unexpectedly, our data suggest innate immune responses are broadly preserved with limited exceptions, and pave the way for further study of the complex relationship between HIV-1 and immunological pathways within macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19109163      PMCID: PMC2637478          DOI: 10.4049/jimmunol.182.1.319

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Granulocyte-macrophage colony-stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages.

Authors:  K Kedzierska; A Maerz; T Warby; A Jaworowski; H Chan; J Mak; S Sonza; A Lopez; S Crowe
Journal:  AIDS       Date:  2000-08-18       Impact factor: 4.177

2.  The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.

Authors:  S Bour; C Perrin; H Akari; K Strebel
Journal:  J Biol Chem       Date:  2001-02-16       Impact factor: 5.157

3.  Comment on "Transcription factor FOXO3a mediates apoptosis in HIV-1-infected macrophages".

Authors:  Mahdad Noursadeghi; Jhen Tsang; Robert F Miller; David R Katz
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

4.  Human macrophage activation programs induced by bacterial pathogens.

Authors:  Gerard J Nau; Joan F L Richmond; Ann Schlesinger; Ezra G Jennings; Eric S Lander; Richard A Young
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 5.  Pathways to neuronal injury and apoptosis in HIV-associated dementia.

Authors:  M Kaul; G A Garden; S A Lipton
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

6.  Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy.

Authors:  S Sonza; H P Mutimer; R Oelrichs; D Jardine; K Harvey; A Dunne; D F Purcell; C Birch; S M Crowe
Journal:  AIDS       Date:  2001-01-05       Impact factor: 4.177

Review 7.  Mechanisms of HIV-associated lymphocyte apoptosis.

Authors:  A D Badley; A A Pilon; A Landay; D H Lynch
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

8.  Modulation of gene expression via disruption of NF-kappaB signaling by a bacterial small molecule.

Authors:  Vladimir V Kravchenko; Gunnar F Kaufmann; John C Mathison; David A Scott; Alexander Z Katz; David C Grauer; Mandy Lehmann; Michael M Meijler; Kim D Janda; Richard J Ulevitch
Journal:  Science       Date:  2008-06-19       Impact factor: 47.728

9.  Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species.

Authors:  Audrey Brussel; Pierre Sonigo
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors.

Authors:  H Akari; S Bour; S Kao; A Adachi; K Strebel
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

View more
  19 in total

1.  HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro.

Authors:  Juan C Hernández; Mario Stevenson; Eicke Latz; Silvio Urcuqui-Inchima
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-12       Impact factor: 2.205

2.  HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral Replication.

Authors:  K Sofia Appelberg; Mark A Wallet; Jared P Taylor; Melanie N Cash; John W Sleasman; Maureen M Goodenow
Journal:  AIDS Res Hum Retroviruses       Date:  2017-04-12       Impact factor: 2.205

3.  Macrophage-mediated responses to Candida albicans in mice expressing the human immunodeficiency virus type 1 transgene.

Authors:  Mathieu Goupil; Emilie Bélanger Trudelle; Véronique Dugas; Catherine Racicot-Bergeron; Francine Aumont; Serge Sénéchal; Zaher Hanna; Paul Jolicoeur; Louis de Repentigny
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

4.  High-dose vitamin D3 reduces deficiency caused by low UVB exposure and limits HIV-1 replication in urban Southern Africans.

Authors:  Anna K Coussens; Celeste E Naude; Rene Goliath; George Chaplin; Robert J Wilkinson; Nina G Jablonski
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-15       Impact factor: 11.205

Review 5.  Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection.

Authors:  Lucy C K Bell; Mahdad Noursadeghi
Journal:  Nat Rev Microbiol       Date:  2017-11-07       Impact factor: 60.633

6.  Kaposi's sarcoma-associated herpesvirus vFLIP and human T cell lymphotropic virus type 1 Tax oncogenic proteins activate IkappaB kinase subunit gamma by different mechanisms independent of the physiological cytokine-induced pathways.

Authors:  Akira Shimizu; Mehdi Baratchian; Yasu Takeuchi; David Escors; Douglas Macdonald; Tracey Barrett; Claire Bagneris; Mary Collins; Mahdad Noursadeghi
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

7.  Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis.

Authors:  Eillen J Rodriguez-Franco; Yisel M Cantres-Rosario; Marines Plaud-Valentin; Rafael Romeu; Yolanda Rodríguez; Richard Skolasky; Viviana Meléndez; Carmen L Cadilla; Loyda M Melendez
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

8.  DC priming by M. vaccae inhibits Th2 responses in contrast to specific TLR2 priming and is associated with selective activation of the CREB pathway.

Authors:  Nina Le Bert; Benjamin M Chain; Graham Rook; Mahdad Noursadeghi
Journal:  PLoS One       Date:  2011-04-01       Impact factor: 3.240

9.  HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation.

Authors:  Jhen Tsang; Benjamin M Chain; Robert F Miller; Benjamin L J Webb; Wendy Barclay; Greg J Towers; David R Katz; Mahdad Noursadeghi
Journal:  AIDS       Date:  2009-11-13       Impact factor: 4.177

10.  HIV-1 infection of macrophages dysregulates innate immune responses to Mycobacterium tuberculosis by inhibition of interleukin-10.

Authors:  Gillian S Tomlinson; Lucy C K Bell; Naomi F Walker; Jhen Tsang; Jeremy S Brown; Ronan Breen; Marc Lipman; David R Katz; Robert F Miller; Benjamin M Chain; Paul T G Elkington; Mahdad Noursadeghi
Journal:  J Infect Dis       Date:  2013-11-21       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.